Gofen & Glossberg LLC Cybin Inc. Call Options Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYBN
# of Institutions
109Shares Held
243MCall Options Held
0Put Options Held
0-
Deep Track Capital, LP Greenwich, CT58.1MShares$15.7 Million0.79% of portfolio
-
Logos Global Management LP San Francisco, CA40MShares$10.8 Million1.53% of portfolio
-
Avidity Partners Management LP Dallas, TX34.9MShares$9.42 Million0.55% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L325.6MShares$6.91 Million1.64% of portfolio
-
Octagon Capital Advisors LP New York, NY18.6MShares$5.02 Million1.19% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $44.9M
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...